FDABridge
← Retour au blog
Général

FDA Stories #018 — A Nigerian Shea Butter Producer Had Two Facilities But Only One Registration

They launched in Saks and Nordstrom. Twelve fragrances. Zero FDA registrations. MoCRA had been in effect for over a year. Nobody in their compliance team knew.

Équipe FDABridge1 janv. 20263 min de lecture

A luxury perfume house based in Grasse, France, had been selling in the US market through department stores for decades. Fragrances, candles, body care — a portfolio of over 40 products. Their US distribution was handled by an American partner who managed retail relationships, marketing, and logistics.

In January 2025, the American partner mentioned during a routine call that they had received an inquiry from a retailer asking whether the brand was MoCRA-compliant. The brand's regulatory team in France had never heard of MoCRA.

What they missed

The Modernization of Cosmetics Regulation Act was signed into law in December 2022. It required cosmetic facility registration and product listing beginning in 2023. The French perfume house had been selling in the US for the entire duration of MoCRA's existence without registering their manufacturing facility or listing any of their products. They had no adverse event reporting system. They had no US Agent designated for cosmetics. They were out of compliance on every MoCRA obligation.

The perfume house's regulatory team was experienced in EU cosmetics regulation — CPNP notifications, Responsible Person designation, Product Information Files, Safety Assessments. They knew European rules inside and out. But MoCRA was a US law, and no one in their compliance department was monitoring US regulatory changes.

What we did

We registered their Grasse manufacturing facility with the FDA under MoCRA within one week. We listed all 40+ products through FDA's Cosmetics Direct system — each product with its full INCI ingredient list, product category, and responsible person information. We designated ourselves as their US Agent. We established an adverse event intake process that routes consumer complaints from their US distributor to the responsible person in France within the MoCRA-required timeline. Total time from first contact to full compliance: 18 business days.

The lesson

MoCRA is new. Many European cosmetic brands — even sophisticated ones with full EU compliance programs — do not know it exists. If you sell cosmetics in the United States and you have not registered under MoCRA, you are out of compliance. The law does not have a grace period for brands that were already in the market before it was enacted. Register now. fdabridge.com/cosmetics.

Besoin d'aide pour la suite ?

Need help choosing a service?

Compare the main service options and choose the filing path that fits your product category.

À lire aussi

Articles connexes

Général

Symboles de marquage des dispositifs médicaux: Ce que les fabricants étrangers doivent savoir pour entrer sur le marché américain

28 avr. 2026

L'étiquetage des dispositifs médicaux aux États-Unis nécessite des symboles spécifiques pour une bonne communication. Les fabricants étrangers doivent comprendre les normes de symboles acceptées par la FDA avant d'exporter les appareils sur le marché américain.

Lire la suite →
Général

Enregistrement des dispositifs médicaux pour les fabricants étrangers: Un guide du système de réglementation américain

26 mars 2026

Les fabricants étrangers de dispositifs médicaux doivent enregistrer leurs établissements, répertorier leurs dispositifs et, selon la classe de dispositifs, obtenir l'approbation ou l'approbation de la FDA avant de les distribuer aux États-Unis.

Lire la suite →
Général

Dix questions à se poser avant d'embaucher un consultant de la FDA

24 mai 2026

Le choix d'un fournisseur de services de conformité de la FDA est une décision conséquente. Ces dix questions aident les fabricants étrangers à séparer les consultants compétents de ceux qui vont créer des problèmes qu'ils ne peuvent pas résoudre.

Lire la suite →